SYRA HEALTH CORP. Increase (Decrease) in Accounts Receivable
SYRA HEALTH CORP. (SYRA) reported Increase (Decrease) in Accounts Receivable of $551.65 thousand for the 6-month period ending 2026-06-30, per its S-1 filed 2026-09-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-09-14
- SYRA HEALTH CORP. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $600.89K.
- SYRA HEALTH CORP. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$49.24K, a 118.58% decline year-over-year.
- SYRA HEALTH CORP. increase (decrease) in accounts receivable for the quarter ending 2025-06-30 was -$59.49K, a 233.96% decline year-over-year.
- SYRA HEALTH CORP. increase (decrease) in accounts receivable for the quarter ending 2025-03-31 was $265.03K.
- SYRA HEALTH CORP. increase (decrease) in accounts receivable for fiscal 2023 was $59.55K, a 93.67% decline from fiscal 2022.
- SYRA HEALTH CORP. increase (decrease) in accounts receivable for fiscal 2022 was $940.47K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $600.89K derived: S-1 6 month − 10-Q 3 month · filed 2026-09-14 | $551.65K S-1 · filed 2026-09-14 | ||
| 2026-03-31 | -$49.24K 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $237.55K S-1 · filed 2026-09-14 | |||
| 2025-06-30 | -$59.49K derived: S-1 6 month − 10-Q 3 month · filed 2026-09-14 | $205.53K S-1 · filed 2026-09-14 | $1.92K derived: sum of 3 quarters · filed 2026-09-14 | $96.27K derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-03-31 | $265.03K 10-Q · filed 2026-05-07 | $61.41K derived: sum of 2 quarters · filed 2026-09-14 | $155.76K derived: sum of 3 quarters · filed 2026-09-14 | $200.17K derived: sum of 4 quarters · filed 2026-09-14 |
| 2024-12-31 | -$203.62K derived: S-1 12 month − 10-Q 9 month · filed 2026-09-14 | -$109.27K derived: sum of 2 quarters · filed 2026-09-14 | -$64.86K derived: sum of 3 quarters · filed 2026-09-14 | -$379.81K S-1 · filed 2026-09-14 |
| 2024-09-30 | $94.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $138.76K derived: sum of 2 quarters · filed 2025-08-12 | -$176.19K 10-Q · filed 2024-10-29 | $19.68K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-06-30 | $44.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$270.54K 10-Q · filed 2025-08-12 | -$74.67K derived: sum of 3 quarters · filed 2025-08-12 | $567.15K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | -$314.95K 10-Q · filed 2025-05-08 | -$119.08K derived: sum of 2 quarters · filed 2025-05-08 | $522.74K derived: sum of 3 quarters · filed 2025-05-08 | $580.05K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $195.87K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $837.69K derived: sum of 2 quarters · filed 2025-03-11 | $895.00K derived: sum of 3 quarters · filed 2025-03-11 | $59.55K 10-K · filed 2025-03-11 |
| 2023-09-30 | $641.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $699.13K derived: sum of 2 quarters · filed 2024-10-29 | -$136.32K 10-Q · filed 2024-10-29 | $448.66K derived: sum of 4 quarters · filed 2024-10-29 |
| 2023-06-30 | $57.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$778.15K 10-Q · filed 2024-08-08 | -$193.16K derived: sum of 3 quarters · filed 2024-08-08 | |
| 2023-03-31 | -$835.46K 10-Q · filed 2024-05-09 | -$250.47K derived: sum of 2 quarters · filed 2024-05-09 | ||
| 2022-12-31 | $584.99K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $940.47K 10-K · filed 2024-03-25 | ||
| 2022-09-30 | $355.48K 10-Q · filed 2023-11-14 |